The outcome of the 2024 Presidential Election in the United States has the potential to significantly impact the healthcare and life sciences sector, shaping policies, regulations, and funding priorities for years to come. With broader issues such as healthcare accessibility, affordability, and innovation, the decisions made by the incoming administration will have far-reaching consequences for stakeholders across the industry. This panel discussion seeks to explore the potential implications of the election outcome on the healthcare and life sciences sector, examining key areas of impact and identifying strategies for navigating the evolving landscape.

• Potential impact on drug pricing, approval and insurance
• For medical devices, will stricter regulations create a fallout akin to the MDR in Europe?
• Evaluating the effect on funding in the biotech, medtech and digital start-up space
• Impact of cyber-security and AI legislation on digital health innovation and implementation